Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Michele Fox

Concepts (268)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cells
9
2025
188
1.620
 Why?
Hematopoietic Stem Cell Transplantation
14
2025
606
1.540
 Why?
Hematopoietic Stem Cell Mobilization
11
2018
60
1.430
 Why?
Multiple Myeloma
27
2025
3049
1.390
 Why?
Blood Component Removal
5
2025
15
1.000
 Why?
Antigens, CD34
10
2025
73
0.840
 Why?
Blood Platelets
5
2017
256
0.780
 Why?
Leukapheresis
4
2025
19
0.660
 Why?
Melphalan
4
2016
181
0.550
 Why?
Bone Marrow Transplantation
4
2016
113
0.530
 Why?
Purpura, Thrombotic Thrombocytopenic
2
2018
14
0.520
 Why?
Antineoplastic Combined Chemotherapy Protocols
7
2024
1031
0.510
 Why?
Plasma Exchange
3
2015
25
0.480
 Why?
Transplantation, Autologous
9
2025
488
0.440
 Why?
Fetal Blood
3
2023
79
0.430
 Why?
Cell Separation
2
2013
74
0.400
 Why?
Pregnant Women
1
2023
70
0.380
 Why?
Killer Cells, Natural
2
2015
116
0.360
 Why?
Humans
44
2025
52336
0.340
 Why?
Cell Proliferation
5
2018
1029
0.340
 Why?
Immunotherapy, Adoptive
2
2015
167
0.330
 Why?
Myelodysplastic Syndromes
2
2013
86
0.330
 Why?
Granulocyte Colony-Stimulating Factor
4
2012
64
0.330
 Why?
Thalidomide
4
2016
377
0.310
 Why?
Blood Transfusion
2
2017
128
0.310
 Why?
Blood Specimen Collection
1
2019
35
0.310
 Why?
Blood Volume
1
2019
63
0.310
 Why?
Education, Distance
1
2019
42
0.300
 Why?
Adult
22
2019
14139
0.290
 Why?
Aged
21
2017
10109
0.290
 Why?
Clinical Laboratory Techniques
1
2018
28
0.290
 Why?
Cryopreservation
2
2025
41
0.280
 Why?
Obstetrics
1
2019
89
0.280
 Why?
Leukocytes, Mononuclear
1
2018
122
0.280
 Why?
Cyclooxygenase Inhibitors
1
2017
39
0.280
 Why?
Flow Cytometry
2
2016
404
0.280
 Why?
Blood Grouping and Crossmatching
1
2017
5
0.270
 Why?
Blood Coagulation
1
2017
60
0.270
 Why?
Chromosome Aberrations
3
2016
297
0.270
 Why?
Middle Aged
21
2018
13014
0.260
 Why?
Aspirin
1
2017
115
0.250
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2017
122
0.250
 Why?
Antibodies
1
2016
152
0.250
 Why?
Erythrocyte Transfusion
2
2015
52
0.250
 Why?
Platelet Aggregation Inhibitors
1
2017
181
0.250
 Why?
Heparin
1
2015
88
0.230
 Why?
Hemoglobins, Abnormal
1
2015
4
0.230
 Why?
Female
22
2023
28105
0.230
 Why?
Thrombocytopenia
1
2015
89
0.230
 Why?
Stem Cell Transplantation
2
2013
185
0.230
 Why?
Factor VIII
1
2014
23
0.230
 Why?
ADAM Proteins
1
2014
21
0.220
 Why?
Leukocytes
2
2011
61
0.220
 Why?
Retrospective Studies
9
2025
6578
0.220
 Why?
Anemia, Sickle Cell
1
2015
101
0.210
 Why?
Internship and Residency
1
2019
449
0.210
 Why?
Follow-Up Studies
8
2024
2268
0.210
 Why?
Male
21
2019
26696
0.210
 Why?
Antiretroviral Therapy, Highly Active
1
2013
32
0.200
 Why?
Leukemia
1
2013
67
0.200
 Why?
Afibrinogenemia
1
2012
5
0.200
 Why?
Neoplasm Recurrence, Local
2
2015
643
0.200
 Why?
Graft Survival
4
2011
160
0.190
 Why?
Aldehyde Dehydrogenase
1
2011
25
0.190
 Why?
Prognosis
6
2018
2094
0.180
 Why?
Transplantation Conditioning
3
2003
93
0.180
 Why?
Boronic Acids
2
2013
183
0.180
 Why?
Pyrazines
2
2013
190
0.180
 Why?
Plateletpheresis
1
2010
7
0.170
 Why?
Blood Preservation
1
2010
27
0.170
 Why?
Transplantation, Homologous
5
2016
150
0.170
 Why?
Blood Proteins
1
2010
84
0.170
 Why?
Anaphylaxis
1
2010
69
0.160
 Why?
Chromosomes, Human, Pair 1
2
2007
96
0.160
 Why?
Cell Survival
5
2011
602
0.160
 Why?
Graft vs Host Disease
5
2003
88
0.150
 Why?
Receptors, KIR
1
2008
12
0.150
 Why?
HIV Infections
1
2013
388
0.150
 Why?
Gene Expression Regulation, Neoplastic
2
2016
858
0.150
 Why?
Myeloablative Agonists
1
2007
32
0.140
 Why?
Cell Movement
2
2006
277
0.140
 Why?
Immunosuppressive Agents
2
2014
243
0.140
 Why?
Treatment Outcome
11
2013
5407
0.140
 Why?
Dexamethasone
3
2024
440
0.130
 Why?
Risk Factors
7
2015
3872
0.130
 Why?
Models, Genetic
1
2006
172
0.130
 Why?
Osteogenesis
2
2006
366
0.120
 Why?
Models, Statistical
1
2007
230
0.120
 Why?
Young Adult
4
2019
4319
0.120
 Why?
Combined Modality Therapy
4
2014
636
0.120
 Why?
Cytokines
2
2006
625
0.120
 Why?
Platelet Count
3
2017
75
0.120
 Why?
Macrophages
1
2018
378
0.120
 Why?
Gene Expression Profiling
2
2007
1110
0.120
 Why?
Incidence
3
2017
1059
0.120
 Why?
Enzyme-Linked Immunosorbent Assay
2
2015
236
0.120
 Why?
Time Factors
1
2010
2957
0.110
 Why?
Antineoplastic Agents
3
2012
1222
0.110
 Why?
Pregnancy
2
2023
2675
0.110
 Why?
Cytotoxicity Tests, Immunologic
2
2016
26
0.110
 Why?
Disease-Free Survival
3
2016
460
0.100
 Why?
Blood Banks
1
2023
18
0.100
 Why?
Bone Marrow Cells
1
2004
190
0.100
 Why?
Metaphase
2
2016
46
0.100
 Why?
Bone Diseases
1
2004
95
0.100
 Why?
Cell Count
3
2011
144
0.100
 Why?
Osteoblasts
1
2006
475
0.100
 Why?
Cyclosporine
1
2003
67
0.100
 Why?
Blood Group Incompatibility
1
2002
4
0.100
 Why?
Tacrolimus
1
2003
60
0.100
 Why?
ABO Blood-Group System
1
2002
15
0.100
 Why?
Universities
1
2023
175
0.090
 Why?
Kaplan-Meier Estimate
3
2007
484
0.090
 Why?
Coculture Techniques
3
2018
145
0.090
 Why?
Osteoclasts
1
2004
428
0.090
 Why?
T-Lymphocyte Subsets
1
2001
41
0.090
 Why?
Models, Biological
1
2004
743
0.090
 Why?
T-Lymphocytes, Cytotoxic
1
2010
66
0.080
 Why?
Lung Diseases
1
2001
86
0.080
 Why?
Prospective Studies
4
2016
2428
0.080
 Why?
Thrombosis
1
2003
253
0.080
 Why?
Heart Failure
1
2006
571
0.080
 Why?
Cancer Vaccines
1
2010
78
0.080
 Why?
Dendritic Cells
1
2010
136
0.080
 Why?
Erythroid Precursor Cells
1
2019
15
0.080
 Why?
Birth Weight
1
2019
124
0.070
 Why?
Hematocrit
1
2018
42
0.070
 Why?
Medical Waste
1
2017
2
0.070
 Why?
Cell Aggregation
1
2017
5
0.070
 Why?
Antineoplastic Agents, Alkylating
2
2008
77
0.070
 Why?
Lymphoma
1
2018
71
0.070
 Why?
Program Evaluation
1
2019
353
0.070
 Why?
Arkansas
2
2017
2028
0.070
 Why?
Lymphoma, Follicular
1
2017
27
0.070
 Why?
Histocompatibility Antigens Class I
1
2017
48
0.070
 Why?
Logistic Models
2
2017
920
0.070
 Why?
Lung
1
2001
502
0.070
 Why?
Adolescent
3
2015
6692
0.070
 Why?
Risk
1
2017
313
0.070
 Why?
Neoplasms
1
2007
1305
0.070
 Why?
Fibrosis
1
2017
197
0.060
 Why?
Dose-Response Relationship, Drug
3
2008
1377
0.060
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2017
106
0.060
 Why?
Curriculum
1
2019
399
0.060
 Why?
Recurrence
2
2008
672
0.060
 Why?
Hemorrhage
1
2017
209
0.060
 Why?
Hemoglobin J
1
2015
3
0.060
 Why?
Hemoglobin, Sickle
1
2015
5
0.060
 Why?
Hemoglobin C
1
2015
6
0.060
 Why?
Blood Donors
1
2015
21
0.060
 Why?
Diagnosis, Differential
1
2018
1044
0.060
 Why?
Neoplasm Proteins
1
2016
334
0.060
 Why?
Reproducibility of Results
1
2017
1214
0.050
 Why?
Age Factors
3
2005
1127
0.050
 Why?
Autoantibodies
1
2014
121
0.050
 Why?
Blotting, Western
1
2015
596
0.050
 Why?
CD4 Lymphocyte Count
1
2013
33
0.050
 Why?
Viral Load
1
2013
80
0.050
 Why?
Transplantation Chimera
3
2003
16
0.050
 Why?
Acute Disease
1
2013
374
0.050
 Why?
Benzylamines
1
2012
14
0.050
 Why?
Receptors, CXCR4
1
2012
29
0.050
 Why?
Immunohistochemistry
1
2015
985
0.050
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2012
51
0.050
 Why?
Heterocyclic Compounds
1
2012
29
0.050
 Why?
Infant, Newborn
1
2019
2826
0.050
 Why?
Clinical Protocols
1
2012
108
0.050
 Why?
Immune Tolerance
1
2011
91
0.040
 Why?
Dimethyl Sulfoxide
1
2010
12
0.040
 Why?
Isotonic Solutions
1
2010
20
0.040
 Why?
Platelet Transfusion
1
2010
33
0.040
 Why?
P-Selectin
1
2010
30
0.040
 Why?
Sodium Chloride
1
2010
56
0.040
 Why?
Platelet Aggregation
1
2010
70
0.040
 Why?
Platelet Activation
1
2010
47
0.040
 Why?
Algorithms
2
2005
668
0.040
 Why?
Multivariate Analysis
2
2007
590
0.040
 Why?
Feasibility Studies
1
2011
402
0.040
 Why?
Hypersensitivity
1
2010
81
0.040
 Why?
Haplotypes
1
2008
94
0.040
 Why?
Nitric Oxide Synthase Type II
1
2018
63
0.040
 Why?
Ligands
1
2008
207
0.040
 Why?
Arginase
1
2018
38
0.040
 Why?
Polyethylene Glycols
1
2008
89
0.040
 Why?
Hemoglobins
1
2008
110
0.040
 Why?
Age Distribution
1
2007
174
0.030
 Why?
Cytogenetic Analysis
1
2007
80
0.030
 Why?
Recombinant Proteins
1
2008
491
0.030
 Why?
Antineoplastic Agents, Hormonal
1
2007
53
0.030
 Why?
Tissue Donors
2
2003
126
0.030
 Why?
Multigene Family
1
2006
50
0.030
 Why?
Mice
2
2018
5965
0.030
 Why?
Chromosome Deletion
1
2007
142
0.030
 Why?
Chromosome Mapping
1
2006
155
0.030
 Why?
In Situ Hybridization, Fluorescence
1
2007
263
0.030
 Why?
Angiogenesis Inhibitors
1
2007
183
0.030
 Why?
Cell Line
1
2008
1045
0.030
 Why?
Interleukin-10
1
2006
84
0.030
 Why?
Cell Communication
1
2006
72
0.030
 Why?
Leukemia, Myeloid, Acute
1
2007
203
0.030
 Why?
Neoplasms, Experimental
1
2006
113
0.030
 Why?
Stroke Volume
1
2006
153
0.030
 Why?
Predictive Value of Tests
1
2007
943
0.030
 Why?
Ventricular Dysfunction, Left
1
2006
106
0.030
 Why?
Myocardial Ischemia
1
2006
125
0.030
 Why?
Mice, Transgenic
1
2006
563
0.030
 Why?
Bromodeoxyuridine
1
2004
19
0.030
 Why?
Receptor Activator of Nuclear Factor-kappa B
1
2004
33
0.030
 Why?
Annexin A5
1
2004
14
0.030
 Why?
Databases, Factual
1
2007
706
0.030
 Why?
Culture Media, Conditioned
1
2004
47
0.030
 Why?
Survival Rate
1
2006
940
0.030
 Why?
Phagocytosis
1
2004
51
0.030
 Why?
Tumor Necrosis Factor-alpha
1
2006
397
0.030
 Why?
Chronic Disease
1
2006
583
0.030
 Why?
Cell Division
1
2004
291
0.030
 Why?
Aged, 80 and over
2
2006
3391
0.030
 Why?
Plasmapheresis
1
2003
12
0.030
 Why?
RANK Ligand
1
2004
187
0.020
 Why?
Membrane Glycoproteins
1
2004
244
0.020
 Why?
Interleukin-6
1
2004
278
0.020
 Why?
Salvage Therapy
2
2003
136
0.020
 Why?
Severity of Illness Index
1
2006
1021
0.020
 Why?
Cohort Studies
1
2006
1532
0.020
 Why?
NF-kappa B
1
2004
328
0.020
 Why?
Red-Cell Aplasia, Pure
1
2002
7
0.020
 Why?
Child
1
2015
7157
0.020
 Why?
Carrier Proteins
1
2004
326
0.020
 Why?
Animals
2
2018
13523
0.020
 Why?
Antigens, CD
1
2003
219
0.020
 Why?
Survival Analysis
2
2003
671
0.020
 Why?
Gene Rearrangement, T-Lymphocyte
1
2001
2
0.020
 Why?
Lymphocyte Count
1
2001
20
0.020
 Why?
Cell Differentiation
1
2004
674
0.020
 Why?
Bronchoalveolar Lavage Fluid
1
2001
40
0.020
 Why?
Clone Cells
1
2001
77
0.020
 Why?
Graft Rejection
1
2002
177
0.020
 Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
 Why?
Disease Models, Animal
1
2006
1484
0.020
 Why?
Hypersensitivity, Delayed
1
2010
18
0.020
 Why?
CD40 Ligand
1
2010
15
0.020
 Why?
Interleukin-4
1
2010
44
0.020
 Why?
Immunity, Cellular
1
2010
64
0.020
 Why?
Adjuvants, Immunologic
1
2010
52
0.020
 Why?
Magnetic Resonance Imaging
1
2007
1543
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2001
132
0.020
 Why?
Interferon-gamma
1
2010
179
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2001
583
0.020
 Why?
CD4-Positive T-Lymphocytes
1
2001
165
0.020
 Why?
Transcription, Genetic
1
2001
385
0.020
 Why?
B-Lymphocytes
1
2010
185
0.020
 Why?
Vaccination
1
2010
297
0.020
 Why?
Stem Cell Factor
1
2003
7
0.010
 Why?
Lymphocyte Transfusion
1
2003
10
0.010
 Why?
Confidence Intervals
1
2003
158
0.010
 Why?
Probability
1
2003
171
0.010
 Why?
Leukocyte Count
1
2003
73
0.010
 Why?
Infusions, Intravenous
1
2003
220
0.010
 Why?
Cyclophosphamide
1
2003
171
0.010
 Why?
Drug Administration Schedule
1
2003
372
0.010
 Why?
Remission Induction
1
2003
218
0.010
 Why?
Administration, Oral
1
2003
451
0.010
 Why?
Doxorubicin
1
2003
239
0.010
 Why?
Neutrophils
1
2003
146
0.010
 Why?
Cisplatin
1
2003
285
0.010
 Why?
Neoplasm Staging
1
2003
770
0.010
 Why?
Drug Resistance, Neoplasm
1
2003
327
0.010
 Why?
Disease Progression
1
2003
870
0.010
 Why?
Fox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (268) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department